Iovance Biotherapeutics Explores a Potential Sale

(Bloomberg) -- Cancer drugmaker Iovance Biotherapeutics Inc. is exploring a sale and has held preliminary talks with potential buyers, according to people familiar with the matter. The stock rose a...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.